Global Health · NSE: MEDANTA · BSE: 543654
Q4 FY26 results · Jan–Mar 2026
Global Health reported revenue from operations of ₹1,159.05 crore (up 24.5% from Q4 FY25) and net profit of ₹141.65 crore (up 39.7% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,159.05 | 931.25 | +24.5% | 1,121.05 | +3.4% |
| Other income | 36.74 | 22.93 | +60.2% | 21.78 | +68.7% |
| Total income | 1,195.79 | 954.18 | +25.3% | 1,142.83 | +4.6% |
| Profit before tax | 187.28 | 133.44 | +40.3% | 119.78 | +56.3% |
| Net profit for the period | 141.65 | 101.38 | +39.7% | 95.03 | +49.1% |
| Attributable to shareholders of the company | 143.99 | 101.40 | +42.0% | 95.02 | +51.5% |
| EPS, basic (₹) | 5.36 | 3.77 | +42.2% | 3.54 | +51.4% |
| Net margin (%) | 12.2 | 10.9 | 8.5 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 960.63 | 802.87 | +19.6% | 940.16 | +2.2% |
| Other income | 35.80 | 25.67 | +39.5% | 24.66 | +45.2% |
| Total income | 996.43 | 828.53 | +20.3% | 964.83 | +3.3% |
| Profit before tax | 163.47 | 125.89 | +29.9% | 102.89 | +58.9% |
| Net profit for the period | 124.13 | 93.41 | +32.9% | 79.91 | +55.3% |
| EPS, basic (₹) | 4.62 | 3.48 | +32.8% | 2.97 | +55.6% |
| Net margin (%) | 12.9 | 11.6 | 8.5 |
Consolidated
- Filed with BSE
- 14 May 2026, 18:09 IST
- Board meeting
- 14 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 14 May 2026, 18:09 IST
- Board meeting
- 14 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE